ZA903564B - Pyrido-pyridazinone acetic acids for treating chronic diabetic complications - Google Patents
Pyrido-pyridazinone acetic acids for treating chronic diabetic complicationsInfo
- Publication number
- ZA903564B ZA903564B ZA903564A ZA903564A ZA903564B ZA 903564 B ZA903564 B ZA 903564B ZA 903564 A ZA903564 A ZA 903564A ZA 903564 A ZA903564 A ZA 903564A ZA 903564 B ZA903564 B ZA 903564B
- Authority
- ZA
- South Africa
- Prior art keywords
- pyrido
- compounds
- diabetic complications
- chronic diabetic
- treating chronic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/350,417 US4996204A (en) | 1989-05-11 | 1989-05-11 | Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA903564B true ZA903564B (en) | 1992-08-26 |
Family
ID=23376622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA903564A ZA903564B (en) | 1989-05-11 | 1990-05-10 | Pyrido-pyridazinone acetic acids for treating chronic diabetic complications |
Country Status (18)
Country | Link |
---|---|
US (1) | US4996204A (da) |
EP (1) | EP0401981B1 (da) |
JP (1) | JPH0631235B2 (da) |
KR (1) | KR920003559B1 (da) |
AT (1) | ATE121743T1 (da) |
AU (1) | AU611610B2 (da) |
CA (1) | CA2016326C (da) |
DE (1) | DE69018876T2 (da) |
DK (1) | DK0401981T3 (da) |
ES (1) | ES2071016T3 (da) |
FI (1) | FI93013C (da) |
HU (1) | HU206714B (da) |
IE (1) | IE66029B1 (da) |
IL (1) | IL94302A (da) |
NO (1) | NO173938C (da) |
NZ (1) | NZ233599A (da) |
PT (1) | PT93984B (da) |
ZA (1) | ZA903564B (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4954629A (en) * | 1989-05-11 | 1990-09-04 | Pfizer Inc. | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
US5716954A (en) * | 1991-10-09 | 1998-02-10 | Syntex U.S.A. Inc. | Benzopyridazinone and pyridopyridazinone compounds |
AU683620B2 (en) * | 1992-09-28 | 1997-11-20 | Pfizer Inc. | Substituted pyrimidines for control of diabetic complications |
GB9314412D0 (en) * | 1993-07-13 | 1993-08-25 | Rhone Poulenc Agriculture | New compositions of matter |
KR100584650B1 (ko) * | 1998-03-31 | 2006-05-30 | 디 인스티튜트스 포 파마슈티컬 디스커버리, 엘엘씨 | 치환된 인돌알칸산 |
TNSN99224A1 (fr) | 1998-12-01 | 2005-11-10 | Inst For Pharm Discovery Inc | Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique |
MXPA03004871A (es) * | 2000-11-30 | 2003-08-19 | Pfizer Prod Inc | Combinacion de agonistas de gaba e inhibidores de aldosa-reductasa. |
ES2240657T3 (es) | 2001-02-28 | 2005-10-16 | Pfizer Products Inc. | Compuestos de sulfonilpiridazinona utiles como inhibidores de aldosa reductasa. |
EE200300470A (et) * | 2001-03-30 | 2004-02-16 | Pfizer Products Inc. | Aldoosreduktaasi püridasinooninhibiitorid |
HUP0303920A3 (en) * | 2001-04-30 | 2004-07-28 | Pfizer Prod Inc | Pharmaceutical compositions containing combinations of aldose reductase inhibitor pyridazinons and cyclooxygenase 2 inhibitors |
AU761191B2 (en) | 2001-05-24 | 2003-05-29 | Pfizer Products Inc. | Therapies for tissue damage resulting from ischemia |
US7572910B2 (en) * | 2003-02-20 | 2009-08-11 | Pfizer, Inc. | Pyridazinone aldose reductase inhibitors |
US8916563B2 (en) | 2010-07-16 | 2014-12-23 | The Trustees Of Columbia University In The City Of New York | Aldose reductase inhibitors and uses thereof |
DK3597650T3 (da) * | 2010-07-16 | 2022-11-21 | Univ Columbia | Aldosereduktasehæmmere og anvendelser deraf |
EP4316603A3 (en) | 2016-06-21 | 2024-04-17 | The Trustees of Columbia University in the City of New York | 4-oxo-3,4-dihydrothieno[3,4-d]pyridazine compounds as aldose reductase inhibitors and methods of use thereof |
EP4417260A2 (en) | 2017-07-28 | 2024-08-21 | Applied Therapeutics, Inc. | Compositions and methods for treating galactosemia |
AU2020268368A1 (en) | 2019-05-07 | 2022-01-06 | Ucl Business Ltd | Treatment and detection of inherited neuropathies and associated disorders |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3821383A (en) * | 1972-07-10 | 1974-06-28 | Ayerst Mckenna & Harrison | Compositions for and a method of treating diabetic complications |
DE2708187A1 (de) * | 1977-02-25 | 1978-08-31 | Thomae Gmbh Dr K | Neue pyrido-pyridazin-one |
IE47592B1 (en) * | 1977-12-29 | 1984-05-02 | Ici Ltd | Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture |
US4209527A (en) * | 1979-05-16 | 1980-06-24 | Pfizer Inc. | Benzimidazolone derivatives |
CA1160518A (en) * | 1979-07-06 | 1984-01-17 | E. I. Du Pont De Nemours And Company | Coated cookware with fep topcoat |
DE3684410D1 (de) * | 1985-11-07 | 1992-04-23 | Pfizer | Heterocyclische oxophthalazinylessigsaeure. |
US4954629A (en) * | 1989-05-11 | 1990-09-04 | Pfizer Inc. | Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof |
-
1989
- 1989-05-11 US US07/350,417 patent/US4996204A/en not_active Expired - Lifetime
-
1990
- 1990-05-06 IL IL9430290A patent/IL94302A/en not_active IP Right Cessation
- 1990-05-08 NZ NZ233599A patent/NZ233599A/en unknown
- 1990-05-09 PT PT93984A patent/PT93984B/pt not_active IP Right Cessation
- 1990-05-09 CA CA002016326A patent/CA2016326C/en not_active Expired - Fee Related
- 1990-05-10 ZA ZA903564A patent/ZA903564B/xx unknown
- 1990-05-10 DE DE69018876T patent/DE69018876T2/de not_active Expired - Fee Related
- 1990-05-10 ES ES90305015T patent/ES2071016T3/es not_active Expired - Lifetime
- 1990-05-10 DK DK90305015.1T patent/DK0401981T3/da active
- 1990-05-10 KR KR1019900006808A patent/KR920003559B1/ko not_active IP Right Cessation
- 1990-05-10 FI FI902335A patent/FI93013C/fi not_active IP Right Cessation
- 1990-05-10 NO NO902070A patent/NO173938C/no unknown
- 1990-05-10 EP EP90305015A patent/EP0401981B1/en not_active Expired - Lifetime
- 1990-05-10 AU AU54905/90A patent/AU611610B2/en not_active Ceased
- 1990-05-10 HU HU902996A patent/HU206714B/hu not_active IP Right Cessation
- 1990-05-10 AT AT90305015T patent/ATE121743T1/de not_active IP Right Cessation
- 1990-05-11 JP JP2122832A patent/JPH0631235B2/ja not_active Expired - Lifetime
- 1990-05-11 IE IE170190A patent/IE66029B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2016326C (en) | 1995-05-30 |
IE66029B1 (en) | 1995-11-29 |
AU611610B2 (en) | 1991-06-13 |
IL94302A0 (en) | 1991-03-10 |
DK0401981T3 (da) | 1995-09-04 |
JPH035481A (ja) | 1991-01-11 |
NO173938C (no) | 1994-02-23 |
KR900018092A (ko) | 1990-12-20 |
PT93984A (pt) | 1991-01-08 |
CA2016326A1 (en) | 1990-11-11 |
HU902996D0 (en) | 1990-09-28 |
FI902335A0 (fi) | 1990-05-10 |
IE901701L (en) | 1990-11-11 |
ES2071016T3 (es) | 1995-06-16 |
DE69018876T2 (de) | 1995-08-24 |
NZ233599A (en) | 1991-07-26 |
JPH0631235B2 (ja) | 1994-04-27 |
IL94302A (en) | 1994-01-25 |
EP0401981A1 (en) | 1990-12-12 |
KR920003559B1 (ko) | 1992-05-04 |
NO902070L (no) | 1990-11-12 |
NO902070D0 (no) | 1990-05-10 |
HUT54683A (en) | 1991-03-28 |
EP0401981B1 (en) | 1995-04-26 |
FI93013C (fi) | 1995-02-10 |
PT93984B (pt) | 1996-11-29 |
FI93013B (fi) | 1994-10-31 |
NO173938B (no) | 1993-11-15 |
US4996204A (en) | 1991-02-26 |
AU5490590A (en) | 1990-11-15 |
HU206714B (en) | 1992-12-28 |
DE69018876D1 (de) | 1995-06-01 |
ATE121743T1 (de) | 1995-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA903564B (en) | Pyrido-pyridazinone acetic acids for treating chronic diabetic complications | |
IE871843L (en) | Indolinone derivatives. | |
EP0905255A3 (en) | Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase | |
DE3071230D1 (en) | Substituted 6-phenethyl-and phenylethenyl-3,4,5,6-tetrahydro-4-hydroxytetraydropyran-2-ones in the4-r trans stereoisomeric forms and the corresponding dihydroxy acids, process for preparing and pharmaceutical composition comprising them | |
IE801005L (en) | Benzimidazolones. | |
HUT62855A (en) | Process for producing glycerol derivatives and pharmaceutical compositions comprising same | |
AU3077289A (en) | Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate | |
JPS6429363A (en) | Heterocyclic derivative | |
AU2742288A (en) | Novel compound effective as cerebral insufficiency improver |